“…In addition, S. proteamaculans 136 was previously reported associated with andrimid production, a potent nanomolar inhibitor pseudopeptide (Sánchez et al, 2013), supported by recent research (Fatiah et al, 2021). On the other hand, the antifungal activity of B. gladioli MB39 was recently described as being related to a mycophagy phenomenon (Sarli et al, 2021), consistent with data obtained in this study and a wide range of antifungal molecules of B. gladioli has also been recently reported (Elshafie et al, 2017; Esmaeel et al, 2017; Kumar et al, 2018; Kunakom & Eustáquio, 2019; Li et al, 2019). In addition, the production of gladiolin, toxoflavin, reumycin, enacyloxin and a putative new compound of molecular formula C 33 H 4 7Cl 2 NO 13 are different compounds produced by B. gladioli recently described by Depoorter et al (2021).…”